Literature DB >> 18603673

Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.

Bita Geramizadeh1, Mahmoud Ravanshad, Marjan Rahsaz.   

Abstract

Renal oncocytoma, conventional RCC (granular cell type) and chromophobe RCC have different prognosis. Sometimes differentiation between them is difficult in HandE slides. In a 5-year study of 128 renal tumors, we selected 76 cases [30 conventional RCC (CRCC), 16 papillary RCC, 21 chromophobe RCC (ChRCC), 8 oncocytoma, 1 collecting duct carcinoma (cdc)] and staining with Hale's colloidal iron, CK7, CK8, CK18, CK19, CK20, Vimentin, EMA, CD10 and RCC marker were done. No significant difference was seen between renal tumor subtypes with CK8, CK18, CK19, CK20 and EMA. The most useful markers were Vimentin, CK7, CD10, RCC marker and Hale's colloidal iron. Hale's colloidal iron staining with diffuse reticular fine cytoplasmic pattern was present in ChRCCs, but was absent in other subtypes and oncocytomas. Vimentin, CK7, CD10, RCC marker and Hale's colloidal iron can be used for the differential diagnosis of problematic epithelial tumors of kidney (CRCC, ChRCC and oncocytoma) - i.e. ChRCC: Vimentin, CD10 and RCC marker - negative, CK7 - positive and positive diffuse fine reticular cytoplasmic pattern of Hale's colloidal iron; oncocytoma: Vimentin, CK7, RCC marker and CD10 - negative and Hale's colloidal iron - negative; CRCC: CK7 - negative, Vimentin, CD10 and RCC marker - positive and Hale's colloidal iron - negative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603673     DOI: 10.4103/0377-4929.41641

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  16 in total

1.  Giant renal oncocytoma: a case report and review of the literature.

Authors:  Sami Akbulut; Ayhan Senol; Bahri Cakabay; Arsenal Sezgin
Journal:  J Med Case Rep       Date:  2010-02-17

2.  Tumor necrosis factor receptor expression and signaling in renal cell carcinoma.

Authors:  Rafia S Al-Lamki; Timothy J Sadler; Jun Wang; Martin J Reid; Anne Y Warren; Mehregan Movassagh; Wanhua Lu; Ian G Mills; David E Neal; Johanna Burge; Peter Vandenebeele; Jordan S Pober; John R Bradley
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

3.  Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria.

Authors:  B Walter; A Hartmann; F Hofstädter; K Junker; H Moch; S Bertz; S Denzinger; W Otto; M Gajda; C G Stoehr
Journal:  Virchows Arch       Date:  2012-02-17       Impact factor: 4.064

4.  Giant asymptomatic left renal oncocytoma in a 40-year-old man: a case report.

Authors:  Sultan Qaid; Radman Ghaleb; Faisal Ahmed; Ebrahim Al-Shami; Qasem Alyhari; Saleh Al-Wageeh; Mohammad Reza Askarpour
Journal:  Pan Afr Med J       Date:  2022-07-05

5.  Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.

Authors:  Jay Amin; Bo Xu; Shervin Badkhshan; Terrance T Creighton; Daniel Abbotoy; Christine Murekeyisoni; Kristopher M Attwood; Thomas Schwaab; Craig Hendler; Michael Petroziello; Charles L Roche; Eric C Kauffman
Journal:  Clin Cancer Res       Date:  2018-05-11       Impact factor: 12.531

6.  Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

Authors:  Keng Lim Ng; Robert J Ellis; Hemamali Samaratunga; Christudas Morais; Glenda C Gobe; Simon T Wood
Journal:  Transl Androl Urol       Date:  2019-05

7.  Two cases of eosinophilic variant chromophobe renal cell carcinoma, with a rare association of right atrial myxoma in one of them.

Authors:  Sunil Kumar Yeshvanth; Harish S Permi; Kishan Prasad Hosapatna Laxminarayana; Teerthanath Shrinivas; Jayaprakash K Shetty
Journal:  J Lab Physicians       Date:  2011-07

Review 8.  Imaging findings of common benign renal tumors in the era of small renal masses: differential diagnosis from small renal cell carcinoma: current status and future perspectives.

Authors:  Sungmin Woo; Jeong Yeon Cho
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

9.  CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.

Authors:  Ariel A Williams; John P T Higgins; Hongjuan Zhao; Börje Ljunberg; James D Brooks
Journal:  BMC Clin Pathol       Date:  2009-11-18

Review 10.  Biopsy of renal masses: when and why.

Authors:  V Anik Sahni; Stuart G Silverman
Journal:  Cancer Imaging       Date:  2009-07-06       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.